0001419041-17-000001.txt : 20170313
0001419041-17-000001.hdr.sgml : 20170313
20170313155232
ACCESSION NUMBER: 0001419041-17-000001
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20170313
DATE AS OF CHANGE: 20170313
EFFECTIVENESS DATE: 20170313
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tocagen Inc
CENTRAL INDEX KEY: 0001419041
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261243872
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-275725
FILM NUMBER: 17685147
BUSINESS ADDRESS:
STREET 1: 3030 BUNKER HILL STREET, SUITE 230
CITY: SAN DIEGO
STATE: CA
ZIP: 92109
BUSINESS PHONE: (858) 412-8400
MAIL ADDRESS:
STREET 1: 3030 BUNKER HILL STREET, SUITE 230
CITY: SAN DIEGO
STATE: CA
ZIP: 92109
D/A
1
primary_doc.xml
X0707
D/A
LIVE
0001419041
Tocagen Inc
3030 BUNKER HILL STREET, SUITE 230
SAN DIEGO
CA
CALIFORNIA
92109
(858) 412-8400
DELAWARE
None
None
Corporation
true
Harry
Gruber
3030 Bunker Hill Street, Suite 230
San Diego
CA
CALIFORNIA
92109
Executive Officer
Director
Thomas
Darcy
3030 Bunker Hill Street, Suite 230
San Diego
CA
CALIFORNIA
92109
Executive Officer
Director
Douglas
Jolly
3030 Bunker Hill Street, Suite 230
San Diego
CA
CALIFORNIA
92109
Executive Officer
Dennis
Berman
3030 Bunker Hill Street, Suite 230
San Diego
CA
CALIFORNIA
92109
Executive Officer
Director
Franklin
M.
Berger
3030 Bunker Hill Street, Suite 230
San Diego
CA
CALIFORNIA
92109
Director
Faheem
Hasnain
3030 Bunker Hill Street, Suite 230
San Diego
CA
CALIFORNIA
92109
Director
David
R.
Parkinson
3030 Bunker Hill Street, Suite 230
San Diego
CA
CALIFORNIA
92109
Director
Paul
R.
Schimmel
3030 Bunker Hill Street, Suite 230
San Diego
CA
CALIFORNIA
92109
Director
Lori
Kunkel
3030 Bunker Hill Street, Suite 230
San Diego
CA
CALIFORNIA
92109
Director
Martin
J
Duvall
3030 Bunker Hill Street, Suite 230
San Diego
CA
CALIFORNIA
92109
Executive Officer
Director
Mark
Foletta
3030 Bunker Hill Street, Suite 230
San Diego
CA
CALIFORNIA
92109
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
true
0001419041-16-000003
2016-11-21
true
true
true
true
false
0
13000000
10895750
2104250
false
107
0
0
0
false
Tocagen Inc
/s/ Mark Foletta
Mark Foletta
Chief Financial Officer
2017-03-10